The present invention provides a compound of formula I processes for preparing such compounds, their the utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, methods for their therapeutic use and pharmaceutical compositions containing them.

 
Web www.patentalert.com

< Use of non-competitive and selective GluR5 antagonists as glutamate receptor modulating compounds

> Q3 SPARC deletion mutant and uses thereof

~ 00497